The World Health Organization (WHO) reported 14 Middle East respiratory syndrome (MERS) cases in May.
A novel dual route vaccination using the Middle East respiratory syndrome coronavirus (MERS-CoV) receptor binding domain sub-unit has been developed.
Dromedary camels play a significant part in the circulation and the zoonotic transmission of Middle East respiratory syndrome coronavirus (MERS-CoV). Researchers demonstrated that Bactrian camels are also susceptible to MERS-CoV infection and shed large quantities of infectious virus in nasal secretions.
Researchers analyzed epidemiologic and clinical data of laboratory-confirmed Middle East respiratory syndrome coronavirus (MERS-CoV) cases from eleven healthcare-associated outbreaks in Saudi Arabia and the South Korea between 2015–2017.
About 50 percent of reported laboratory-confirmed infections of Middle East respiratory syndrome coronavirus (MERS-CoV) have occurred in healthcare settings, with healthcare workers constituting over a third of all secondary infections.
The study found the research, case fatality rate was 30.5 percent for males and 25.8 percent for females.
Early Middle East respiratory syndrome (MERS) diagnosis may require more sensitive risk assessment tools to reduce delays related to patients and health system.
The study investigated risk factors for Middle East respiratory syndrome (MERS) seropositivity in animal market and slaughterhouse workers at a site previously associated with zoonotic transmission of MERS. Given the large number of camels present, including many young camels, and the mixing of camels from multiple sources, this site probably facilitates MERS transmission among camels. Results demonstrated a relatively high MERS seroprevalence in workers at this site, ranging from six percent to 19 percent at each round across all occupations.
Researchers made two versions of a potential vaccine and evaluated their effectiveness and safety in mice that were genetically altered to have more human-like immune responses. After the mice were vaccinated and then infected with Middle East respiratory syndrome (MERS), both vaccines protected the mice against clinical signs of disease and death.
The Saudi Ministry of Health is reporting two more Middle East respiratory syndrome (MERS) cases from Al Khafji , both of which are currently listed as `under investigation'. As with the previous four cases, all are older males.